Intuitive Surgical, Inc. $ISRG Stock Bought by Knights of Columbus Asset Advisors LLC

Knights of Columbus Asset Advisors LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 187.2% in the 3rd quarter, Holdings Channel.com reports. The fund owned 18,905 shares of the medical equipment provider’s stock after acquiring an additional 12,322 shares during the quarter. Knights of Columbus Asset Advisors LLC’s holdings in Intuitive Surgical were worth $7,687,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of ISRG. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Intuitive Surgical during the second quarter worth about $14,316,000. Plato Investment Management Ltd purchased a new position in shares of Intuitive Surgical in the 2nd quarter valued at approximately $4,315,000. Hikari Power Ltd purchased a new position in shares of Intuitive Surgical in the 2nd quarter valued at approximately $5,619,000. NewEdge Advisors LLC raised its position in shares of Intuitive Surgical by 19.1% in the 2nd quarter. NewEdge Advisors LLC now owns 50,825 shares of the medical equipment provider’s stock valued at $20,212,000 after purchasing an additional 8,142 shares during the last quarter. Finally, Concurrent Investment Advisors LLC boosted its stake in Intuitive Surgical by 30.8% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 25,639 shares of the medical equipment provider’s stock worth $10,196,000 after purchasing an additional 6,043 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ISRG has been the topic of several research analyst reports. Raymond James Financial reissued an “outperform” rating and set a $480.00 target price on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $486.00 price target (down from $487.00) on shares of Intuitive Surgical in a report on Wednesday, October 21st. Sanford C. Bernstein reiterated an “outperform” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, August 14th. Finally, Royal Bank Of Canada cut their target price on Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $493.54.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,150 shares of the company’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $460.00, for a total value of $529,000.00. Following the sale, the director directly owned 1,150 shares of the company’s stock, valued at approximately $529,000. This represents a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $457.34, for a total value of $4,573,400.00. Following the sale, the director directly owned 1,194,530 shares in the company, valued at $546,306,350.20. This represents a 0.83% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 39,056 shares of company stock worth $17,585,864. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Down 2.3%

Intuitive Surgical stock opened at $450.04 on Wednesday. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The company has a market capitalization of $156.00 billion, a price-to-earnings ratio of 54.42, a price-to-earnings-growth ratio of 3.17 and a beta of 1.45. The stock has a 50-day moving average price of $413.15 and a 200 day moving average price of $431.20.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same quarter in the prior year, the firm earned $2.40 earnings per share. Intuitive Surgical’s revenue for the quarter was up 21.7% on a year-over-year basis. Research analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.